These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

840 related articles for article (PubMed ID: 27230049)

  • 1. Dystrophin-Deficient Cardiomyopathy.
    Kamdar F; Garry DJ
    J Am Coll Cardiol; 2016 May; 67(21):2533-46. PubMed ID: 27230049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac Involvement in Duchenne Muscular Dystrophy and Related Dystrophinopathies.
    Mavrogeni SI; Markousis-Mavrogenis G; Papavasiliou A; Papadopoulos G; Kolovou G
    Methods Mol Biol; 2018; 1687():31-42. PubMed ID: 29067654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac Involvement Classification and Therapeutic Management in Patients with Duchenne Muscular Dystrophy.
    Fayssoil A; Abasse S; Silverston K
    J Neuromuscul Dis; 2017; 4(1):17-23. PubMed ID: 28269790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiomyopathy in Duchenne muscular dystrophy: pathogenesis and therapeutics.
    Fayssoil A; Nardi O; Orlikowski D; Annane D
    Heart Fail Rev; 2010 Jan; 15(1):103-7. PubMed ID: 19943106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are there real benefits to implanting cardiac devices in patients with end-stage dilated dystrophinopathic cardiomyopathy? Review of literature and personal results.
    Palladino A; Papa AA; Morra S; Russo V; Ergoli M; Rago A; Orsini C; Nigro G; Politano L
    Acta Myol; 2019 Mar; 38(1):1-7. PubMed ID: 31309174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dystrophin analysis in carriers of Duchenne and Becker muscular dystrophy.
    Hoogerwaard EM; Ginjaar IB; Bakker E; de Visser M
    Neurology; 2005 Dec; 65(12):1984-6. PubMed ID: 16380627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenges and opportunities in dystrophin-deficient cardiomyopathy gene therapy.
    Duan D
    Hum Mol Genet; 2006 Oct; 15 Spec No 2(SPEC):R253-61. PubMed ID: 16987891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current understanding and management of dilated cardiomyopathy in Duchenne and Becker muscular dystrophy.
    Kaspar RW; Allen HD; Montanaro F
    J Am Acad Nurse Pract; 2009 May; 21(5):241-9. PubMed ID: 19432907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological management of dilated cardiomyopathy in Duchenne muscular dystrophy: A systematic review.
    Haddad CN; Ali S; Stephanou D; Assakura MS; Sahagian L; Trogkanis E
    Hellenic J Cardiol; 2023; 74():58-64. PubMed ID: 37406964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac assessment in duchenne and becker muscular dystrophies.
    Romfh A; McNally EM
    Curr Heart Fail Rep; 2010 Dec; 7(4):212-8. PubMed ID: 20857240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac Involvement in Dystrophin-Deficient Females: Current Understanding and Implications for the Treatment of Dystrophinopathies.
    Lim KRQ; Sheri N; Nguyen Q; Yokota T
    Genes (Basel); 2020 Jul; 11(7):. PubMed ID: 32650403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duchenne Muscular Dystrophy Mice and Men: Can Understanding a Genetic Cardiomyopathy Inform Treatment of Other Myocardial Diseases?
    Rafael-Fortney JA; Chadwick JA; Raman SV
    Circ Res; 2016 Apr; 118(7):1059-61. PubMed ID: 27034274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in Dystrophinopathy Diagnosis and Therapy.
    Saad FA; Siciliano G; Angelini C
    Biomolecules; 2023 Aug; 13(9):. PubMed ID: 37759719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characterisation of Becker muscular dystrophy patients predicts favourable outcome in exon-skipping therapy.
    van den Bergen JC; Schade van Westrum SM; Dekker L; van der Kooi AJ; de Visser M; Wokke BH; Straathof CS; Hulsker MA; Aartsma-Rus A; Verschuuren JJ; Ginjaar HB
    J Neurol Neurosurg Psychiatry; 2014 Jan; 85(1):92-8. PubMed ID: 23667215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Female carrier of Duchenne muscular dystrophy presenting with secondary dilated cardiomyopathy: a case report].
    Hiramatsu S; Maekawa K; Hioka T; Takagaki K; Shoji K
    J Cardiol; 2001 Jul; 38(1):35-40. PubMed ID: 11496434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of dystrophin deletion mutations predicts age of cardiomyopathy onset in becker muscular dystrophy.
    Kaspar RW; Allen HD; Ray WC; Alvarez CE; Kissel JT; Pestronk A; Weiss RB; Flanigan KM; Mendell JR; Montanaro F
    Circ Cardiovasc Genet; 2009 Dec; 2(6):544-51. PubMed ID: 20031633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel mutation of dystrophin in a Becker muscular dystrophy family with severe cardiac involvement: from genetics to clinicopathology.
    Chen L; Ren J; Chen X; Chen K; Rao M; Zhang N; Yu W; Song J
    Cardiovasc Pathol; 2018; 36():64-70. PubMed ID: 30103083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic predictors and remodeling of dilated cardiomyopathy in muscular dystrophy.
    Jefferies JL; Eidem BW; Belmont JW; Craigen WJ; Ware SM; Fernbach SD; Neish SR; Smith EO; Towbin JA
    Circulation; 2005 Nov; 112(18):2799-804. PubMed ID: 16246949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNAs in Dystrophinopathy.
    Lee A; Moon J; Yu J; Kho C
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887128
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 42.